MarketScreener Strategies Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 02:41:56 23/06/26 am AEST			5-day change	1st Jan Change
3.005 ^USD	+1.86%		+2.55%	+9.64%

03/06	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
03/06	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

No results match your criteria